Sign in
Taking people in United StatesNo phase

Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation

Key facts

Who runs it
Cedars-Sinai Medical Center
Where
Los Angeles, United StatesSee the site
Trial code
Status
Recruiting
People taking part
60 people, planned
Started
19 Feb 2025
Expected to end
Aug 2027
Type of study
Observational, 2 groups
Record updated
26 May 2026

Who can take part

Age
60 years and older
Sex
Women and men
Healthy volunteers
Cannot take part

The registry criteria, word for word

Show all 4 criteriaShow less

Who can take part

  • Patients older than 60 years who have DMR will be included in the study

Who cannot take part

  • Patients with prior history of mitral intervention or surgery will be excluded
  • Persons with allergy to animal dander or animal-instigated asthma will be excluded
  • Patient records flagged "break the glass" or "research opt out" will be excluded

This trial is currently available in United States.

  • Smidt Heart Institute, Cedars Sinai Medical CenterLos Angeles, United StatesContact: Aakriti Gupta, M.D.Taking people

About the trial

What the trial wants to find out

The goal of this observational study is to compare the outcomes of transcatheter edge-to-edge repair (TEER) versus surgical mitral valve repair for degenerative mitral regurgitation (DMR) over the long term. The study aims to:

Read full original descriptionShow less

1. Evaluate the effectiveness and safety of TEER versus surgery in patients with DMR over long term. 2. Investigate the predictors of left ventricular dysfunction and clinical outcomes using advanced imaging techniques, such as cardiac MRI 3. Assess patient-reported recovery and quality of life outcomes using validated tools.

The study focuses on improving care strategies for patients with DMR, particularly those at higher surgical risk, by identifying optimal treatment approaches and predictors of recovery.

The 2 groups in the trial

  • Surgical mitral repair

    This cohort includes patients who underwent surgical mitral valve repair for severe degenerative mitral regurgitation (DMR). The intervention involves standard surgical techniques to repair the mitral valve, aiming to restore its physiological function and reduce mitral regurgitation.

  • Transcatheter mitral edge-to-edge repair

    This cohort includes patients who underwent transcatheter edge-to-edge repair (TEER) for severe degenerative mitral regurgitation (DMR). The intervention involves a minimally invasive transcatheter procedure using a device to approximate the mitral valve leaflets, reducing regurgitation.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Transcatheter vs. Surgical Treatment of Degenerative Mitral Regurgitation: A Comparative Study of Clinical Outcomes, Patient Experiences, and Mechanistic Insights With Multimodality Imaging
Record updated
26 May 2026